Atlas Trials

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Clinical trial NCT06408324 · COMPLETED

Trial details

NCT number
NCT06408324
Sponsor
European Research Consortium on ITP
Status
COMPLETED
Study type
OBSERVATIONAL
Primary Immune Thrombocytopenia (ITP)
Start date
2022-11-24
Primary completion
2024-04-05
Enrollment
275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.